Prostate-specific membrane antigen inhibitors and their uses
CL202600686A1Pending Publication Date: 2026-07-31SHANGHAI SINOTAU BIOTECH CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202600686
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-09-11
- Filing Date
- 2026-03-09
- Publication Date
- 2026-07-31
Abstract
A compound with Formula (I), a pharmaceutical composition comprising said compound, and a method of using the compound or the pharmaceutical composition in the diagnosis or treatment of a disease or disorder, for example, a disease or disorder characterized by overexpression of prostate-specific membrane antigen (PSMA), are provided herein.
Need to check novelty before this filing date? Find Prior Art